Long-Term Effectiveness of Baricitinib and Other b/tsDMARDs in Patients with Rheumatoid Arthritis with Early Low Disease Activity or Remission: 2-Year Data from the RA-BE-REAL Study.

Alten R, Östör A, Edwards CJ, Smolen JS, Haladyj E, Ng KJ, Ogwu S, Kaneko Y

Open source

DOI
10.1007/s40744-025-00815-0
Published
2026 Feb
Container
Rheumatology and therapy
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40744-025-00815-0,
  title = {Long-Term Effectiveness of Baricitinib and Other b/tsDMARDs in Patients with Rheumatoid Arthritis with Early Low Disease Activity or Remission: 2-Year Data from the RA-BE-REAL Study.},
  author = {Alten R and Östör A and Edwards CJ and Smolen JS and Haladyj E and Ng KJ and Ogwu S and Kaneko Y},
  year = {2026},
  journal = {Rheumatology and therapy},
  doi = {10.1007/s40744-025-00815-0},
  url = {https://doi.org/10.1007/s40744-025-00815-0}
}

RIS

TY  - JOUR
TI  - Long-Term Effectiveness of Baricitinib and Other b/tsDMARDs in Patients with Rheumatoid Arthritis with Early Low Disease Activity or Remission: 2-Year Data from the RA-BE-REAL Study.
AU  - Alten R
AU  - Östör A
AU  - Edwards CJ
AU  - Smolen JS
AU  - Haladyj E
AU  - Ng KJ
AU  - Ogwu S
AU  - Kaneko Y
PY  - 2026
JO  - Rheumatology and therapy
DO  - 10.1007/s40744-025-00815-0
UR  - https://doi.org/10.1007/s40744-025-00815-0
ER  - 

APA

R, A., A, Ö., CJ, E., JS, S., E, H., KJ, N., S, O., & Y, K. (2026). Long-Term Effectiveness of Baricitinib and Other b/tsDMARDs in Patients with Rheumatoid Arthritis with Early Low Disease Activity or Remission: 2-Year Data from the RA-BE-REAL Study.. Rheumatology and therapy. https://doi.org/10.1007/s40744-025-00815-0

Source records